Author:
Wang Min,Liao Qiao,Xu Ru,Song Dandan,Huang Jieting,You Qingzhu,Shan Zhengang,Huang Ke,Rong Xia,Fu Yongshui
Funder
National Natural Science Foundation of China
Weigao Fund of Chinese society of blood transfusion
Publisher
Springer Science and Business Media LLC
Subject
Virology,General Medicine
Reference43 articles.
1. Mohd Hanafiah K, Groeger J, Flaxman AD, Wiersma ST (2013) Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence. Hepatology 57:1333–1342
2. Chen YS, Li L, Cui FQ, Xing WG, Wang L, Jia ZY, Zhou MG, Gong XH, Wang FZ, Zheng H, Luo HM, Bi SL, Wang N, Yang WZ, Liang XF (2011) A sero-epidemiological study on hepatitis C in China. Zhonghua liu xing bing xue za zhi 32:888–891
3. National Institutes of Health (2002) NIH consensus statement on management of hepatitis C: 2002. NIH Consen State Sci Statement 19:1–46
4. Strader DB, Wright T, Thomas DL, Seeff LB, American Association for the Study of Liver D (2004) Diagnosis, management, and treatment of hepatitis C. Hepatology 39:1147–1171
5. Abrignani S, Houghton M, Hsu HH (1999) Perspectives for a vaccine against hepatitis C virus. J Hepatol 31(Suppl 1):259–263
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献